(NYSE American: VTAK) ("VTAK" or the "Company"), today announced continued operational growth following the launch of its enhanced digital booking platform, During the first six months of 2026, Flyte ...
Catheter Precision Inc. VTAK shares jumped 17.39% to $1.08 after the bell on Tuesday, as investors cheered the firm’s ...
Flyte is an in-home treatment designed to strengthen and treat weakened pelvic floor muscles. The Food and Drug Administration (FDA) has granted clearance for Flyte™ (Pelvital), a noninvasive, ...
NEW YORK--(BUSINESS WIRE)--Intellihealth, a leading health-tech software and clinical services company that delivers a comprehensive and clinically proven medical model for treating obesity, is ...
Eight New Patents Issued on Heart Failure TechnologyThree New Patents Granted on Vascular Closure TechnologyFORT MILL, S.C., June 22, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results